Tobias Bäuerle Selected Research

leukocyte procoagulant activity

1/2017

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Bäuerle Research Topics

Disease

34	Neoplasms (Cancer) 05/2022 - 06/2005
24	Neoplasm Metastasis (Metastasis) 05/2022 - 06/2005
17	Breast Neoplasms (Breast Cancer) 06/2013 - 06/2005
9	Inflammation (Inflammations) 11/2021 - 01/2016
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2018
6	Fibrosis (Cirrhosis) 01/2020 - 01/2016
5	Arthritis (Polyarthritis) 11/2020 - 01/2017
4	Ewing Sarcoma (Sarcoma, Ewing) 11/2021 - 09/2016
4	Osteolysis 06/2012 - 05/2008
3	Bone Resorption 11/2020 - 10/2011
3	Chronic Renal Insufficiency 01/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 12/2013 - 04/2010
2	Alcoholism (Alcohol Abuse) 03/2022 - 12/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 07/2020
2	Multiple Sclerosis 01/2021 - 11/2019
2	Atherosclerosis 10/2020 - 02/2016
2	Demyelinating Diseases (Demyelinating Disease) 07/2020 - 01/2020
2	Multiple System Atrophy 01/2020 - 01/2016
2	Edema (Dropsy) 11/2019 - 01/2018
2	Nephrocalcinosis 01/2018 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2016 - 11/2009
1	Obesity 05/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Nephrogenic Fibrosing Dermopathy 09/2021
1	Neuroinflammatory Diseases 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Adenocarcinoma 01/2021
1	Root Resorption 12/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2020
1	Embolism (Embolus) 10/2020
1	Renal Insufficiency (Renal Failure) 10/2020
1	Infarction (Infarctions) 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020
1	Synovitis 02/2020
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2006
7	Pharmaceutical PreparationsIBA 01/2021 - 06/2010
6	AntigensIBA 01/2021 - 04/2018
6	IntegrinsIBA 01/2018 - 01/2011
5	Contrast MediaIBA 09/2021 - 08/2012
5	technetium 99m 1- (1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)- 2- ((1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)methyl)- 9,14- dioxo- 2,8,13,15- tetraazaoctadecane- 7,12,16,18- tetracarboxylic acid)IBA 08/2020 - 04/2018
5	Integrin-Binding SialoproteinIBA 06/2012 - 06/2005
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 05/2008
4	CilengitideIBA 04/2013 - 01/2011
3	Circulating Tumor DNAIBA 11/2021 - 01/2020
3	LigandsIBA 01/2021 - 04/2018
3	CytokinesIBA 01/2019 - 10/2018
3	OsteopontinIBA 05/2016 - 04/2010
3	Zoledronic Acid (Zometa)FDA Link 09/2014 - 01/2007
3	Sunitinib (Sutent)FDA Link 09/2014 - 06/2010
2	PPAR gammaIBA 05/2022 - 12/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2022 - 01/2011
2	bisphenol AIBA 05/2022 - 12/2021
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 03/2022 - 12/2021
2	Tumor Biomarkers (Tumor Markers)IBA 11/2021 - 09/2016
2	InflammasomesIBA 11/2021 - 01/2018
2	Complement System Proteins (Complement)IBA 11/2021 - 01/2017
2	GadoliniumIBA 09/2021 - 02/2020
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2019 - 10/2019
2	gallium 68 PSMA-11IBA 10/2019 - 10/2018
2	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 10/2019 - 10/2018
2	EnzymesIBA 01/2019 - 11/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 06/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2016
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2017
2	Biological ProductsIBA 01/2018 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 02/2016
2	Calcium OxalateIBA 01/2018 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 07/2012 - 06/2010
2	Bevacizumab (Avastin)FDA Link 02/2010 - 05/2008
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	TOR Serine-Threonine KinasesIBA 11/2021
1	abemaciclibIBA 01/2021
1	LuciferasesIBA 01/2021
1	SaltsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	SodiumIBA 01/2021
1	DeuteriumIBA 01/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 11/2020
1	FibrinIBA 10/2020
1	CholesterolIBA 10/2020
1	Deoxyribonuclease I (Nickase)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Clopidogrel (Plavix)FDA Link 10/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	AndrogensIBA 08/2020
1	alpha-SynucleinIBA 07/2020
1	CuprizoneIBA 07/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020

Therapy/Procedure

23	Therapeutics 05/2022 - 10/2009
4	Aftercare (After-Treatment) 01/2021 - 10/2009
2	Radiotherapy 08/2020 - 01/2019
1	Immunotherapy 01/2021
1	Tooth Movement Techniques 12/2020